Analyst Ranking
Top 31%
#1730 out of 5532 analysts
Average Return
+1.89%
Win Rate
44%16 out of 36
Risk vs Reward
Poor
Good

Vik Chopra's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Alphatec Holdings IncATEC
+59.34%$6.64$10.58
2024-08-01 -
2025-07-31
Strong Buy
Neuropace IncNPCE
+56.22%$9.32$14.56
2025-08-13 -
2026-08-12
Strong Buy
Neuropace IncNPCE
+47.54%$9.15$13.50
2024-11-13 -
2025-11-12
Strong Buy
Globus Medical IncGMED
+40.41%$58.65$82.35
2025-08-08 -
2026-08-07
Strong Buy
Neuropace IncNPCE
+37.67%$6.77$9.32
2024-08-14 -
2025-08-13
Strong Buy

Vik Chopra's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Integra Lifesciences Holdings CorpIART
5Hold$15.00+12.87%Maintains
a day ago
Envista Holdings CorpNVST
6Hold$26.00+11.40%Maintains
8 days ago
Dentsply Sirona IncXRAY
6Hold$10.00+16.82%Maintains
19 days ago
Alphatec Holdings IncATEC
4Buy$12.00+11.94%Maintains
2 months ago
Zimmer Biomet Holdings IncZBH
1Hold$95.00+3.75%Initiates Coverage On
3 months ago
Intuitive Surgical IncISRG
1Buy$518.00+27.44%Initiates Coverage On
3 months ago
Teleflex IncTFX
1Buy$159.00+26.96%Initiates Coverage On
3 months ago
Enovis CorpENOV
6Buy$29.00+55.16%Initiates Coverage On
3 months ago
Align Technology IncALGN
6Buy$209.00+48.60%Initiates Coverage On
3 months ago
Solventum CorpSOLV
6Hold$83.00-5.71%Maintains
7 months ago
Globus Medical IncGMED
12Strong Buy$104.00+35.82%Maintains
7 months ago
Henry Schein IncHSIC
4Hold$87.00+3.29%Maintains
7 months ago
Masimo CorpMASI
11Hold$180.00+0.03%Downgrades
8 months ago
Conmed CorpCNMD
7Hold$42.00-11.26%Maintains
8 months ago
Neuropace IncNPCE
4Strong Buy$16.00+21.03%Maintains
a year ago
Nuvasive IncNUVA
2Hold$57.72N/ADowngrades
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.